Tonix Pharmaceuticals Holding Corp (LTS:0A4T)
$ 134.6 0 (0%) Market Cap: 17.80 Mil Enterprise Value: 12.04 Mil PE Ratio: 0 PB Ratio: 0.40 GF Score: 31/100

Tonix Pharmaceuticals Holding Corp at Noble Capital Markets Investor Conference (Virtual) Transcript

Apr 21, 2022 / 01:30PM GMT
Release Date Price: $134.6
Seth Lederman
Tonix Pharmaceuticals Holding Corp. - Chairman & CEO

Good morning. My name is Seth Lederman. I'm the CEO of Tonix Pharmaceuticals, and I'm grateful to you for coming to see the presentation. I'm grateful to the organizers for having us speak. Today, I've got a lot to say. I'm going to try to fit it into the time we have.

We have some exciting new analyses that have never been presented before about Long COVID, which is one of our programs. And I'm going to talk about the relationship of Long COVID to fibromyalgia, which is another condition which Tonix has a program in.

But first, let me take a breath and say Tonix is a public company. We're traded on NASDAQ under the ticker TNXP, and I will be making forward-looking statements, and I refer you to our SEC documents for more complete information about the company.

One of the most distinctive things about Tonix is the broad portfolio of products that we have in development. So we have an engine of discovery, manufacturing, regulatory, clinical development, and other things. And that's why it's been efficient

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot